ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Histology One Year Post-Kidney Transplant Relates to Risk of Alloimmune-Mediated Graft Failure Long Term

M. El Ters, L. Cornell, E. Rodrigo, M. Keddis, A. Muriithi, M. Stegall, F. Cosio

Nephrology,Transplant Center, Mayo Clinic, Rochester, MN
Pathology, Mayo Clinic, Rochester, MN
Surgery, Transplant Center, Mayo Clinic, Rochester, MN

Meeting: 2013 American Transplant Congress

Abstract number: 36

Introduction. One year protocol biopsies (PBx) distinguish a large group of grafts with normal histology/mild fibrosis (GIF) and low risk of failure (LwR) from a smaller group of grafts with moderate/severe GIF, inflammation, or chronic antibody-mediated rejection (cAMR) that have high risk (HiR). We investigated causes of graft loss in LwR and HiR and the relationship between 1 year histology and cause of long term death-censored graft loss (GL).

Methods. Included are 818 negative crossmatch, adult recipients of transplants from 1998-2008 with 1 year PBx. Age 52±14; 73% living donors; f/u 84±37 months. Grafts with recurrent disease at 1 year were excluded. 78% received thymoglobulin induction and 85% triple immunosuppression with tacrolimus. GL were classified as alloimmune (GLA, acute rejection (AR) or cAMR) or non-alloimmune (recurrent disease, medical illness, etc.).

Results. At 1 year, 625 of 818 grafts (76.4%) were LwR. Compared to LwR, HiR had higher risk of GL beyond year 1 [HR=6.45 (4.24-9.82), p<0.0001] independently of graft function, AR, HLA mismatches (HLAmm) or donor specific antibodies (DSA). 34 of 95 GL (36%) occurred in LwR and 61 (64%) in HiR. HiR had markedly increased risk of GLA [HR=13.3 (6.60-26.8), p<0.0001). For example, cAMR caused 15% of GL in LwR and 43% in HiR (p<0.0001). In patients with high immunologic risk (i.e. DSA pre-transplant, HLAmm>3, re-transplants, AR) PBx histology also related to risk of GL. Thus, compared to patients without DSA, GLA was markedly increased in patients with DSA and HiR but not in those with DSA and LwR. Similarly, in patients with HLAmm>3, retransplants or AR the risk of GL was increased only in those with HiR in 1year PBx. Of interest, the percent of HiR grafts has declined progressively over time (OR=0.89 (0.84-0.95), p<0.0001) and consequently the %LwR grafts increased from 69.4% to 84.2% since 1998 to present.

Conclusions. Clinical/subclinical noxious events during the 1st year post-transplant result in changes in 1 year graft histology that predicts future risk of alloimmune GL. Still, a relatively large number of “low risk” grafts are lost largely due to non-alloimmune causes. One year graft histology is a modifiable endpoint that measures success of therapy during the 1st year and predicts future risk of alloimmune graft loss.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ters MEl, Cornell L, Rodrigo E, Keddis M, Muriithi A, Stegall M, Cosio F. Histology One Year Post-Kidney Transplant Relates to Risk of Alloimmune-Mediated Graft Failure Long Term [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/histology-one-year-post-kidney-transplant-relates-to-risk-of-alloimmune-mediated-graft-failure-long-term/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences